- Feature Paper
- Article
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
- Ketki Bhise,
- Samaresh Sau,
- Razieh Kebriaei,
- Seth A. Rice,
- Kyle C. Stamper,
- Hashem O. Alsaab,
- Michael J. Rybak and
- Arun K. Iyer
Vancomycin is the treatment of choice for infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Clinically, combinations of vancomycin (VAN) and beta-lactams have been shown to improve patient outcomes compared to VAN alone for the...

